It’s hard to identify which clinical trials pregnant and lactating patients can join. Here’s one fix, experts write.
Final Overall Survival Analysis of S1500: A Randomized, Phase II Study Comparing Sunitinib With Cabozantinib, Crizotinib, and Savolitinib in Advanced Papillary Renal Cell Carcinoma The conduct of ...
The HALO trial showed that baxdrostat 0.5 mg, 1 mg, or 2 mg daily did not significantly reduce BP compared with placebo among patients with uncontrolled HTN. In this phase 2 study, patients were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results